Introduction &
Bone turnover is a continuous physiological process depending on the balance between bone formation and resorption. This balance involves the coordinated regulation and interaction of two cell types: the osteoclast (OC) and the osteoblast (OB) [1, 2] . The OPG / RANKL / RANK system is fundamental for regulation between the OBs and OCs [3, 4] Previous in vitro studies of OPG / RANK / RANKL regulation have used stromal cells, immature primary osteoblasts, and osteoblast cell lines. Recent studies using cell lines induced to diff erentiate into a more mature osteoblastic phenotype have indicated that RANKL and OPG expression levels can be altered [5, 6] . However, expression models of RANKL and OPG have not been established during primary human osteoblastic diff erentiation. Only Thomas et al. [7] have demonstrated that RANKL and OPG expression is diff erent during the growth of murine osteoblastic cells. An OB cell has diff erent levels or stages of maturity during its growth. At each stage the pheno- Abstract &
The OPG / RANKL system in primary cultures of human osteoblasts has been studied by diff erent authors. However, very few studies have been performed on gene expression of RANKL and OPG at diff erent stages of maturation on human osteoblast cultures. The eff ect of 17--estradiol and 1,25dihydroxyvitamin D3 on the OPG / RANKL system is not known during the diff erent states of cellular maturation. In this work we quantifi ed OPG and RANKL protein levels (ELISA) and the mRNA of OPG, RANKL, collagen type I, alkaline phosphatase, and osteocalcin (semi-quantitative RT-PCR) in human osteoblasts. We analyzed these in basal conditions and after incubation with 17--estradiol and 1,25dihydroxyvitamin D3 in the fi rst and second phases. We found that OPG secretion and expression levels increased throughout cellular growth. RANKL proteins were detected only in the fi rst stage, and the expression increased throughout the fi rst phase. Thus, the RANKL / OPG ratio was higher in immature osteoblasts than in mature osteoblasts. The evolution of RANKL gene expression was related to collagen I and alkaline phosphatase, while OPG was related to osteocalcin. We observed no modifi cations after estradiol and 1,25dihydroxyvita-min D3 treatment. Our results suggest that the OB is a positive stimulator at precocious stages of diff erentiation on osteoclastogenic modulates. Therefore the main aim of this study was to examine OPG and RANKL expression and secretion in primary cultures of human OBs throughout their developmental sequences. The second point was to analyze the response of the RANKL / OPG system to 17--estradiol and 1,25dihydroxyvitamin D3 throughout the diff erent maturation stages. The fi nal goal was to relate the OPG and RANKL gene expression with the expression of other genes implicated in bone structural proteins such as osteocalcin (BGP), collagen type 1 (COL 1), and alkaline phosphatase (ALP) during the proliferation and maturation of osteoblasts.
Materials and Methods

& Cell culture
Primary human OB (hOB) cells were isolated from bone fragments taken from four patients (3 women and 1 man, aged 58 -72 years), without bone metabolic disease, who had undergone knee or hip arthroplasty due to the diagnosis of osteoarthritis. Ethical approval had been obtained from the local Research Ethics Committee. Briefl y, trabecular bone was cut into pieces (1 -2 mm) and thoroughly rinsed with PBS six times. The cells from each donor were examined individually, they were incubated in a humidifi ed CO 2 incubator at 37 ° C, and the medium was changed twice a week until confl uence was achieved. This was defi ned as fi rst passage cells. hOB was cultured in -DMEM supplemented with 10 % FCS and antibiotics. In all the cultures, >85 % of the cells showed intense staining for alkaline phosphatase activity. Trypan blue was used to screen out dead cells after harvesting. We tested cells at 14 and 28 d and at confl uence, and then 300 000 cells / plate were sub-cultured and tested again after 14 and 28 d in the second passage. We confi rmed the osteoblastic phenotype by using alkaline phosphatase staining.
Histochemical detection of ALP
After rinsing monolayer cells with PBS, the cells were fi xed in 3.7 % . formaldehyde and 90 % ethanol solution for 2 min and washed in TBS for 10 min. Then, the cells were stained with fast 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium (BCIP / NBT) alkaline phosphatase substrate (Amresco, Ohio, USA) for 10 min at room temperature. The reaction was stopped by removing the substrate solution and washing with distilled water.
Cell treatment with E2 and vitD
Confl uent hOB cultures were then washed and incubated in a serum-free medium for 24 h. The concentration used for each agent was as follows: 10 -6 M 17--estradiol and 10 -8 M 1,25dihy-droxyvitamin D3.
Measurement of OPG secretion
OPG levels were analyzed using an ELISA (Immundiagnostik, Bensheim and Biomedia, Vienna). Briefl y, the samples and biotinylated antibody against OPG reacted simultaneously with the pre-coated antibody on the microtiter plate; in a second step, streptavidin-peroxidase, which reacts with the detection antibody, was added, and the solid phase was incubated with the substrate, TMB. An acidic stopping solution was subsequently added. A dose -response curve of the absorbance units (at 450 nm) versus concentration was generated. The OPG present in samples was determined directly from the calibration curve.
The detection limit was 0.14 pmol / 1, the intra-assay variation was 4 % , and the inter-assay variation was < 10 % . Protein concentrations were normalized to the number of cells.
Measurement of sRANKL secretion
sRANKL levels were analyzed using an ELISA (Immundiagnostik, Bensheim and Biomedica, Vienna). In a fi rst step, the sample and biotinylated anti-sRANKL detection antibodies were pipetted into the wells. Human sRANKL, if present in the sample, binds to the pre-coated recombinant osteoprotegerin (OPG) and forms a sandwich within the detection antibody. Streptavidin -HRP conjugate was added to the wells, and then TMB was added as a substrate. A dose -response curve of absorbance units (at 450 nm against 690 nm or 620 nm as a reference) versus concentration was generated. The sRANKL present in the samples was determined directly from the calibration curve. The detection limit was 0.08 pmol / l, the intra-assay variation was 4 % , and the interassay variation was 9 % . Protein concentrations were normalized to the number of cells.
Semi-quantitative RT-PCR for the mRNAs of OPG, RANKL, ALP, COLI, and BGP
The cells were lysed and the RNA was isolated using a High Pure RNA Isolation Kit (Roche, Germany) according to the manufacturer ' s instructions. Total RNA was quantifi ed by measuring the OD at 260 nm. An amount of 0.2 g was amplifi ed by RT-PCR using a Titan One Tube Kit (Roche, Germany); primers and conditions are presented in Table 1 . Amplifi ed products were analyzed by 2 % agarose gel electrophoresis and visualized with ethidium bromide. Band densities were measured using a Scion Image 4.0.2. (Maryland, USA) computer software program. The relative expression of the diff erent transcripts was calculated as a ratio to the -actin signal.
Statistical analysis
Statistical comparisons were carried out by ANOVA using the SPSS 14.0. software (Illinois, USA). The correlations between variables were carried out by Pearson coeffi cient. The critical value for signifi cance was p < 0.05.
Results &
Primary human osteoblast cultures progressed throughout the osteoblastic development sequence. All the cultures behaved homogenously, and cellular confl uence was reached between 33 and 35 d after starting the culture.
Osteoclastogenesis regulatory proteins
OPG protein secretion was detected at all the time points analyzed, although the higher levels were reached at 14 d of the second passage, with a signifi cant increase regarding the fi rst study point (p = 0.003). ( ᭹ ᭤ Fig. 1A ). sRANKL protein secretion was detected only in the initial phase of osteoblastic proliferation, with a decrease of 96 % at day 28 of the fi rst passage with respect to the initial value, while it was not detectable in the rest of the determinations ( ᭹ ᭤ Fig. 1B ).
The treatment with estrogens and 1,25D for 24 h apparently did not exert any eff ect on the OPG secretion when we analyzed the joint data from the four patients. There was a decrease of between 14 and 58 % in two patients and an increase of between 6 and 162 % in the other two patients. Secondly, on analyzing Downloaded by: IP-Proxy Universidad de Sevilla, Universidad de Sevilla. Copyrighted material.
sRANKL, while the levels were undetectable on the 28th day of the second passage in three out of four patients, after stimulating with E2 + 1,25D, the patients presented sRANKL secretion in the culture medium, thus indicating a positive net eff ect on this protein.
There was a negative correlation between the values of OPG and sRANKL secretion throughout cellular growth, with r = − 0.332, p = 0.036.
Osteoblast phenotype
The mRNA levels were measured by semi-quantitative RT-PCR. The expression pattern of key genes such as COL1, ALP, and BGP was evident throughout the cellular culture, with higher concentrations for COL1 and ALP on the 28th day of the fi rst passage and for BGP at the moment of cellular confl uence in the fi rst phase. Although no signifi cant diff erences were found for any of the genes among the points studied, we were able to verify that the maximum increase in ALP values was 5 times the initial value, while it was 3.5 times for BGP expression. ( ᭹ ᭤ Fig. 2A -C ) . mRNA expression of OPG was nearly unchanged in two out of four patients, and the other two underwent a decrease in the range of 2.2 -20 % . We observed no apparent change in RANKL expression.
Osteoclastogenesis regulatory genes
The OPG mRNA levels were measured by semi-quantitative RT-PCR. These levels progressively increased throughout culture development until the 28th day of the second passage, when values were highest. The overall increase was 32 % , with signifi cant diff erences between day 28 of the fi rst passage and its cellular confl uence in the same passage (p = 0.031) ( ᭹ ᭤ Fig. 1C , Table 2 ). Cellular stimulation with estrogens and 1,25dihydroxyvitamin D3 did not induce any apparent change in OPG expression during culture with regard to the results of cellular cultures in basal conditions. We were able to observe a positive correlation between OPG mRNA and BGP mRNA values (r = 0.716, p = 0.001). RANKL expression kept within the same range of values in the fi rst passage; however, it decreased signifi cantly in the second passage, where values fell up to 3.5 times with respect to the maximum values obtained on day 28 of the fi rst passage (p = 0.024) ( ᭹ ᭤ Fig. 1D , Table 2 ). Once again, the E2 and 1,25D stimuli did not modify the RANKL expression throughout the study with regard to the values obtained in nontreated cells. RANKL mRNA levels were correlated with those found for ALP (r = 0.479, p = 0.012) and for COL1 (r = 0.405, p = 0.029). The modulation of osteoclastogenic activity is related to the RANKL / OPG ratio, and we observed that this ratio decreased during culture time until reaching the lowest values at the last point studied. This means that in the initial studies of cell growth, OBs modulate osteoclastogenic activity positively in the system ( ᭹ ᭤ Fig. 2D , Table 2 ).
Discussion &
In the present study we have shown that the patterns of diff erent genes change throughout the time of hOBs cultures. The cultures were obtained from bone biopsies of adult patients who had undergone knee or hip arthrodesis. All of them similarly reached cellular confl uence at 33 -35 d. During their growth, the percentage of cells obtained at each time of analysis was very similar. Confl uence time was very similar to that obtained by other authors for primary osteoblastic cultures from hip bone biopsies [14 -16] , between 3 and 6 weeks, although it was more prolonged than that of other species such as rat primary OBs [17] or chicken embryo calvarial cells [18] , which took 6 -8 d, or hOBs from other sources such as iliac crest biopsies [9] , which reached cellular confl uence after 21 d of culture. There are three osteoblastic developmental phases [17] : an initial proliferative phase characterized by higher COL1 expression, followed by a matrix production and maturation phase in which ALP is increased, and, fi nally, a third phase of initiation of mineralization marked by higher levels of BGP mRNA. We detected COL1, ALP, and BGP levels throughout the culture growth up to cellular confl uence. We were able to verify that the highest levels corresponded with day 28 of the fi rst passage for the gene expression of COL1 and ALP. At the moment of cellular confl uence for BGP mRNA in the second passage, the levels were maintained, and we did not detect signifi cant changes in the levels of mRNA of these genes. There are very few studies that have evaluated the expression of these genes in the fi rst phases of cellular growth hOBs, and our results coincide with these studies [11, 14] . Expression of OPG and RANKL, key osteoblast regulatory genes, has hardly been studied throughout the development of the osteoblastic growth phases, although there are multiple authors who have studied OPG and RANKL expression at the moment of cellular confl uence. Some have also studied OPG and RANKL protein secretion but found problems in detecting the latter [12, 19] . Although the soluble form of sRANKL in the medium is well known [20, 21] , its detection has been diffi cult. We have detected soluble RANKL secretion in culture medium in the most precocious phases of cellular growth; in fact, only the determination carried out on the 14th day of the fi rst culture passage showed sRANKL levels above the minimum threshold of sensibility of the test. Other authors have not found soluble levels of RANKL in the hOB culture medium, mainly because the sRANKL determinations were performed at later stages of cellular growth [22] . We did not evaluate the RANKL form anchored to a membrane in this study and, therefore, do not know whether this protein is modifi ed throughout the diff erentiation phases and cellular maturation. Other studies will be necessary to determine this. In the present study we wanted to analyze protein secretion as well as OPG and RANKL expression during the growth of hOB cultures, fi rst by evaluating the most incipient growth phases until cellular confl uence was reached and then by relating the levels of these genes at the diff erent time points with COL1, BGP, and ALP genes. Protein secretion as well as OPG expression were higher in studies of more immature cultures, coinciding with the BGP maximum peak (beginning of cellular maturation phase). These results have also been described in murine OBs in post-confl uent growth [7] and in hOB cellular lines [23] . The behavior of sRANKL was diff erent, with the highest secretion at the beginning of cellular culture and a sharp decrease from then onwards, reaching undetectable levels during the follow-up. This could explain the fact that some authors do not fi nd a soluble form of the protein in the culture medium when they refer to the moment of cellular confl uence [19, 22] . RANKL gene expression was also greater at the beginning of cellular culture and coincided with ALP and COL1 expression, indicative of immature cells in the proliferative phase. These results are similar to the data shown by Gori et al. [23] . The RANKL / OPG mRNA ratio, indicative of positive modulation osteoclastogenic activity, showed higher values in the initial phases of the study, coinciding with more immature OBs, and decreased progressively in the latter phases of cellular maturation [23] . This makes us believe that the stimulation of osteoclastogenesis is a major role of immature osteoblasts. It would be necessary to perform, in the future, in vitro studies with both cellular types, osteoblasts and osteoclasts, and to observe this phenomenon throughout the diff erent phases of cellular growth and development. Although the in vitro observations could not necessarily be extrapolated to in vivo physiologic mechanisms, we believe that the regulation of the RANKL / OPG ratio observed in vitro during cellular growth could contribute, in vivo, to the coordination of osteoblastic diff erentiation and osteoclastic activity. E2 and 1,25D are hormones that infl uence bone turnover activity. Several in vitro studies have evaluated the eff ect each one has on the OPG / RANKL system, showing contradictory results [19, 24, 25] . In our case the results were not consistent, showing a stimulating eff ect on some cultures and inhibitory eff ects on others. We chose concentrations of 10 -6 M E2 and 10 -8 M 1,25D
after performing previous studies of dose -response curves and observing that these concentrations showed higher activity. We used a combination of E2 and 1,25D because we were able to verify that the joint eff ect of both hormones induced more potent osteoblastic activity than each one did separately, coinciding with data from other authors [26, 27] . This greater eff ect could be due to the upregulation of the estrogenic receptors by 1,25D when both substances are present, as other groups have proposed [28, 29] . This led us to use a combination of both substances as a stimulus in the development of primary human cultures; however, we saw no relevant eff ect on the genes studied that could be related to the dose and time of incubation employed.
Overall, it appears that the diff erentiation over time is much stronger in regulating RANKL and OPG than E2 and 1,25D are. Thus, when assays to evaluate the eff ect of diff erent pharmaceutical treatments on osteoblasts are designed, we have to bear in mind at what stage of proliferation and / or maturation the cell cultures are found [14] . In this work we did not measure the or estrogen receptor (ER) concentrations in hOB cultures, which could limit our understanding of the results. Nevertheless, the existence of ER in OBs has been repeatedly observed, though at very low concentrations, which could justify the scarce response found [30 -32] .
In conclusion, in this study we have shown that human OB differentiation in vitro is associated with a high RANKL / OPG production ratio in early cellular growth stages [23, 33] . We speculate that human OBs have a positive eff ect on modulating the osteoclastogenic activity at precocious stages of its cellular growth which is lost on reaching a higher degree of cellular maturation and that may contribute to the coordinated sequence of bone turnover cycles.
